O
BIOA

OrbiMed’s BioAge Labs BIOA Stock Holding History

OrbiMed’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.4M Sell
711,811
-79,090
-10% -$1.52M 0.27% 74
2025
Q4 		$10.5M Hold
790,901
– – 0.21% 79
2025
Q3 		$4.65M Sell
790,901
-131,058
-14% -$614K 0.11% 86
2025
Q2 		$3.81M Hold
921,959
– – 0.1% 83
2025
Q1 		$3.47M Hold
921,959
– – 0.08% 86
2024
Q4 		$5.34M Sell
921,959
-501,511
-35% -$8.65M 0.11% 85
2024
Q3 		$29.6M Buy
+1,423,470
New +$28.5M 0.54% 50

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return